Literature DB >> 12118388

Intensity-modulated radiation therapy for prostate cancer.

Michael J Zelefsky1, Zvi Fuks, Steven A Leibel.   

Abstract

Intensity-modulated radiation therapy (IMRT) represents a new paradigm in radiation treatment planning and delivery for treatment of prostate cancer with enormous potential. Preliminary data indicate that this highly conformal treatment technique can effectively reduce acute and late-occurring toxicities, improving the quality of life of the treated patient and serving as the optimal dose escalation tool. IMRT produces radiation distributions capable of delivering different dose prescriptions to multiple target sites, providing a new opportunity for differential dose painting to increase the dose selectively to specific, image-defined regions within the prostate. Clinical trials will be necessary to define more clearly the true extent of improved tumor control and reduction in normal tissue complications with IMRT in the treatment of prostate cancer. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12118388     DOI: 10.1053/srao.2002.00000

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  19 in total

1.  On Voxel based Iso-Tumor Control Probabilty and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity Modulated Radiotherapy.

Authors:  Yusung Kim; Wolfgang A Tomé
Journal:  Imaging Decis (Berl)       Date:  2008

2.  Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans.

Authors:  Yusung Kim; Wolfgang A Tome
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

3.  Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.

Authors:  Douglas J Moseley; Elizabeth A White; Kirsty L Wiltshire; Tara Rosewall; Michael B Sharpe; Jeffrey H Siewerdsen; Jean-Pierre Bissonnette; Mary Gospodarowicz; Padraig Warde; Charles N Catton; David A Jaffray
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-01       Impact factor: 7.038

4.  Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer.

Authors:  Matthew D Schmitz; Gilbert D A Padula; Patrick Y Chun; Alan T Davis
Journal:  Radiat Oncol       Date:  2010-09-16       Impact factor: 3.481

Review 5.  Intensity-modulated radiation therapy for gastrointestinal tumors.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

Review 6.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

7.  Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts.

Authors:  Eric S Wisenbaugh; Paul E Andrews; Robert G Ferrigni; Steven E Schild; Sameer R Keole; William W Wong; Sujay A Vora
Journal:  Rev Urol       Date:  2014

8.  Adjuvant chemoradiation for localized rectal cancer: current trends and future directions.

Authors:  Lisa A Kachnic
Journal:  Gastrointest Cancer Res       Date:  2007

9.  Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial.

Authors:  Sonja Krause; Florian Sterzing; Dirk Neuhof; Lutz Edler; Juergen Debus; Klaus Herfarth
Journal:  BMC Cancer       Date:  2012-10-31       Impact factor: 4.430

Review 10.  Radiosensitization in prostate cancer: mechanisms and targets.

Authors:  Diego A Palacios; Makito Miyake; Charles J Rosser
Journal:  BMC Urol       Date:  2013-01-26       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.